Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-16,873
Closed -$3.3M 175
2024
Q3
$3.3M Sell
16,873
-344
-2% -$63.4K 0.42% 62
2024
Q2
$2.98M Sell
17,217
-359
-2% -$59.7K 0.4% 63
2024
Q1
$2.97M Sell
17,576
-296
-2% -$55.4K 0.43% 62
2023
Q4
$3.53M Sell
17,872
-805
-4% -$143K 0.59% 58
2023
Q3
$3.25M Buy
18,677
+259
+1% +$47K 0.63% 52
2023
Q2
$3.17M Sell
18,418
-457
-2% -$79K 0.6% 58
2023
Q1
$3.14M Sell
18,875
-115
-0.6% -$18.8K 0.63% 52
2022
Q4
$2.78M Buy
18,990
+1,366
+8% +$202K 0.62% 57
2022
Q3
$2.61M Buy
17,624
+509
+3% +$85.1K 0.62% 54
2022
Q2
$2.94M Buy
17,115
+1,463
+9% +$253K 0.7% 48
2022
Q1
$2.95M Buy
15,652
+1,117
+8% +$221K 0.62% 52
2021
Q4
$3.55M Buy
+14,535
New +$3.18M 0.99% 39

Other funds holding ZTS

Bensler's ZTS Position: Q4 2024 in Review

Bensler sold out of Zoetis (ZTS) in Q4 2024, closing a stake of 16,873 shares — an estimated $3.3M sold.

Bensler first reported a position in ZTS in Q4 2021 and held it in 12 quarters. The position peaked at $3.55M in Q4 2021. 1,875 funds tracked by Wall St. Rank hold ZTS as of Q4 2024.

  • Bensler reported no remaining Zoetis position as of Q4 2024 after selling out during the quarter.
  • Bensler sold 16,873 Zoetis shares in Q4 2024, an estimated $3.3M.
  • Bensler first reported a position in Zoetis in Q4 2021 and held it in 12 quarters.
  • Bensler's Zoetis position peaked at $3.55M in Q4 2021.
  • 1,875 funds tracked by Wall St. Rank held Zoetis as of Q4 2024.

Based on Bensler's 13F filing for Q4 2024, filed 22 Jan 2025.